Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease Six-month Interim Results Expected in 1H 2026 with Topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback